Evidence map›Paper›PMID 36298612›Full record

ArticleVaccines2022

Identifying Modifiable Predictors of COVID-19 Vaccine Side Effects: A Machine Learning Approach.

Sara Abbaspour, Gregory K Robbins, Kimberly G Blumenthal, Dean Hashimoto, Karen Hopcia, Shibani S Mukerji, Erica S Shenoy, Wei Wang, Elizabeth B Klerman

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sara AbbaspourDepartment of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0001-8294-861X
Gregory K RobbinsDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0001-7545-5817
Kimberly G BlumenthalHarvard Medical School, Boston, MA 02114, USA.ORCID 0000-0003-4773-9817
Dean HashimotoHarvard Medical School, Boston, MA 02114, USA.
Karen HopciaOccupational Health Services, MassGeneralBrigham, Boston, MA 02114, USA.ORCID 0000-0001-9724-5634
Shibani S MukerjiHarvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-5677-6954
Erica S ShenoyDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0001-8086-1123
Wei WangDivision of Sleep Medicine, Harvard Medical School, Boston, MA 02114, USA.
Elizabeth B KlermanDepartment of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-7402-3171
Harvard University · USBrigham and Women's Hospital · USMassachusetts General Hospital · USMass General Brigham · US

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
The roles of NK3RMnPO and KNDy neurons in vasomotor symptoms, sleep, and cognition in E2 depleted mice.U54AG062322 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Ursula B. Kaiser · 2020 to 2026
$13.7M
A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson's DiseaseU01NS114001 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI VIDENOVIC, ALEKSANDAR · 2019 to 2021
$6.5M
Molecular and Physiological Mechanisms of Hypertensive Cerebral MicroangiopathyR01NS114526 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GUROL, MAHMUT EDIP · 2020 to 2024
$4.4M
Bright light modulation of non-motor symptoms in Parkinson's diseaseR01NS099055 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI VIDENOVIC, ALEKSANDAR · 2017 to 2021
$3.0M
Testing Effects of Melatonin on Uterine Contractions in WomenR01HD107064 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI KLERMAN, ELIZABETH B. · 2022 to 2025
$3.0M
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-InfectionK23MH115812 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MUKERJI, SHIBANI SHARON · 2018 to 2022
$926k
The Clinical and Economic Impact of Penicillin AllergyK01AI125631 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BLUMENTHAL, KIMBERLY GOLD · 2016 to 2021
$779k
Treatment of Restless Legs Symptoms with Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical TrialR21DA052861 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WINKELMAN, JOHN W · 2021 to 2022
$462k
DoD W81XWH201076Leducq Foundation for Cardiovascular Research NANCATS NIH HHS UL1 TR002541NIAID NIH HHS K01 AI125631NIA NIH HHS U54 AG062322NICHD NIH HHS R01 HD107064NIDA NIH HHS R21 DA052861NIH R01 NS099055NIMH NIH HHS K23 MH115812NINDS NIH HHS R01 NS099055NINDS NIH HHS R01 NS114526NINDS NIH HHS U01 NS114001R01 HD102624R01 NS114526-02S1R21 DA052861U01 NS114001U54 AG062322
6 · The paper itself

Abstract

Side effects of COVID-19 or other vaccinations may affect an individual's safety, ability to work or care for self or others, and/or willingness to be vaccinated. Identifying modifiable factors that influence these side effects may increase the number of people vaccinated. In this observational study, data were from individuals who received an mRNA COVID-19 vaccine between December 2020 and April 2021 and responded to at least one post-vaccination symptoms survey that was sent daily for three days after each vaccination. We excluded those with a COVID-19 diagnosis or positive SARS-CoV2 test within one week after their vaccination because of the overlap of symptoms. We used machine learning techniques to analyze the data after the first vaccination. Data from 50,484 individuals (73% female, 18 to 95 years old) were included in the primary analysis. Demographics, history of an epinephrine autoinjector prescription, allergy history category (e.g., food, vaccine, medication, insect sting, seasonal), prior COVID-19 diagnosis or positive test, and vaccine manufacturer were identified as factors associated with allergic and non-allergic side effects; vaccination time 6:00-10:59 was associated with more non-allergic side effects. Randomized controlled trials should be conducted to quantify the relative effect of modifiable factors, such as time of vaccination.

Indexed as

allergyCOVID-19machine learningmodel explanationside effectstime-of-day-effectsvaccination

Identifiers

PMID36298612
PMCPMC9608090
OpenAlexW4306857275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.